Short- and long-term anxiety and depression in women recalled after breast cancer screening

Lampic, Claudia; Thurfjell, Erik; Bergh, Jonas; Sjödén, Per‐Olow

doi:10.1016/s0959-8049(00)00426-3

Cited by 128 publications

(113 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, internal consistency and factorial structure are good, and because in the BBP group there was a high correlation (r=0.91) between fatigue at 3 and 6 months, test-retest reliability also appeared good. Furthermore, the response rate is approximately 62%, which is comparable with other studies [18] that include patients before diagnosis is known. This is probably caused by feelings of uncertainty or stress surrounding the diagnosis.…”

Section: High Extravertedsupporting

confidence: 84%

Personality and fatigue in patients with benign or malignant breast disease

Michielsen

Steeg

Roukema

et al. 2007

Support Care Cancer

View full text Add to dashboard Cite

Goals of work The aim of the study was to examine the role of five general personality traits in fatigue in a group of patients with breast cancer (BC) and a group with benign breast problems (BBP). Materials and methods Of the 304 participating women, 127 patients had BC and 177 BBP. A fatigue scale was completed before diagnosis and 1, 3, and 6 months after diagnosis (benign patients) or surgical treatment (BC patients). A personality questionnaire (NEO-FFI) and a depression scale (CES-D) were completed before diagnosis. Main results The BC group was less tired before diagnosis, more tired 1 month after diagnosis, and equally tired 3 and 6 months after diagnosis. In the total group, women were more tired over time when they were more neurotic, less agreeable, or more introverted. After controlling for depressive symptoms, demographics, and medical factors, baseline depressive symptoms (β=0.29, p<0.05), neuroticism (β=0.29, p<0.05), and extraversion (β=−0.25, p< 0.05) predicted fatigue 6 months later. After also including baseline fatigue, only neuroticism (β=0.22, p<0.05) and baseline fatigue (β=0.79, p<0.001) predicted fatigue.Conclusions Personality is more strongly related to fatigue than demographics, the diagnosis cancer, receiving cancer treatment, and baseline depressive symptoms and fatigue. When replicated, screening and treating women who are at risk to experience high levels of fatigue is recommended.

show abstract

Section: High Extravertedsupporting

confidence: 84%

Personality and fatigue in patients with benign or malignant breast disease

Michielsen

Steeg

Roukema

et al. 2007

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…The most significant effects are observed in women referred for further assessment with false-positive results. While most studies have found increased anxiety in those women to be fairly short-lived (Cockburn et al, 1994;Ellman and Thomas, 1995;Lampic et al, 2001), some have reported long-term effects (Lerman et al, 1991). However a false-positive result does not appear to deter women from subsequent attendance for screening (Lerman et al, 1991;Lightfoot et al, 1994).…”

Section: False-positive Resultsmentioning

confidence: 99%

Should women under 50 be screened for breast cancer?

Moss

2004

Br J Cancer

View full text Add to dashboard Cite

Despite some controversy in recent years, the majority of experts agree on the evidence for effectiveness of breast screening by mammography for women aged 50 years and above, but for those under 50 years, the picture is much less clear. However, the issue remains of importance both to policy makers and to individual women; although the incidence of breast cancer is lower at younger ages, the life years lost due to cancers diagnosed below 50 years amount to a third of all those lost due to the disease. This article summarises the current position in different countries, and reviews the most recent evidence on effectiveness of screening women below 50 years from randomised trials. It has not been conducted as a systematic review or meta-analysis, of which a number have been performed. It also addresses the range of potential disadvantages of screening with particular reference to this age group.

show abstract

“…Some studies indicate that, while women show increased distress between receiving the information about the need for a follow-up appointment and receiving the all-clear, in the longer term their anxieties about breast cancer and mammography are not increased. [53][54][55] Other studies report that there are long-term adverse psychological consequences to receiving a falsepositive mammogram. 56,57,59,103 The outcomes of studies looking at whether having false-positive results affects future attendance at breast screening appointments is similarly conflicted.…”

Section: Decision Problemmentioning

confidence: 99%

Systematic review of the psychological consequences of false-positive screening mammograms

Bond

Pavey²,

Welch³

et al. 2013

Health Technol Assess

142

108

View full text Add to dashboard Cite

Reports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Clinical Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.hta.ac.uk/ This reportThe research reported in this issue of the journal was funded by the HTA programme as project number 09/145/01. The contractual start date was in March 2011. The draft report began editorial review in November 2011 and was accepted for publication in June 2012. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health. Background: In the UK, women aged 50-73 years are invited for screening by mammography every 3 years. In 2009-10, more than 2.24 million women in this age group in England were invited to take part in the programme, of whom 73% attended a screening clinic. Of these, 64,104 women were recalled for assessment. Of those recalled, 81% did not have breast cancer; these women are described as having a false-positive mammogram.

show abstract

Short- and long-term anxiety and depression in women recalled after breast cancer screening

Cited by 128 publications

References 23 publications

Personality and fatigue in patients with benign or malignant breast disease

Personality and fatigue in patients with benign or malignant breast disease

Should women under 50 be screened for breast cancer?

Systematic review of the psychological consequences of false-positive screening mammograms

Contact Info

Product

Resources

About